文献速递妇科

HPV感染与宫颈上皮内瘤变锥切标本中宫颈管腺体受累的关系

The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
PubMed 文献 · Gynecol Oncol · 2020-10-09

研究纳入1301例宫颈活检后行锥切术的女性,评估组织学宫颈管腺体受累(EGI)与高危HPV感染及治疗后CIN持续/复发的关系。结果显示EGI发生率为46.3%,HPV16是唯一与EGI增加显著相关的高危型别,EGI阳性者CIN2+病变比例更高且治疗后持续/复发风险增加。

要点

  • 锥切标本EGI发生率为46.3%,HPV16感染与EGI显著相关(OR=1.41)。
  • EGI阳性者CIN2+病变比例为86.7%,显著高于EGI阴性者的40.5%。
  • EGI阳性者治疗后CIN2+持续/复发风险增加(OR=2.35)。

核心结论

  • 组织学EGI与HPV16感染、多重高危HPV感染及CIN2+病变增加相关。
  • EGI阳性者治疗后CIN持续/复发风险高于阴性对照。

研究设计与样本

  • 纳入1301例宫颈活检后行锥切术的女性,其中持续CIN1 533例,CIN2+ 768例(含20例微小浸润癌)。
  • 采用INNO-LiPA HPV基因分型检测宫颈刮片HPV型别,用逻辑回归和Cox回归分析EGI与CIN持续/复发的关系。

主要发现

  • 最终组织学EGI发生率为46.3%(602/1301)。
  • HPV16是唯一与EGI增加显著相关的高危HPV型别(231/602 vs 211/699,p=0.002)。
  • EGI与多重高危HPV感染增加相关(237/602 vs 225/699,p=0.006)。
  • EGI阳性者CIN2+病变比例为86.7%(522/602),阴性者为40.5%(283/699),p<0.001。

关键数值与推荐

  • 1090例治疗女性中位随访25个月(IQR=15-47),EGI阳性者随访期间HPV16持续率为38.1%(93/217,p=0.03 vs EGI阴性),对照为32%(58/181)。
  • 校正潜在混杂因素后,EGI阳性者CIN2+持续和/或复发的OR为2.35(95%CI=1.16-4.77),高于阴性对照。

临床怎么用

  • 锥切标本发现EGI时,应关注HPV16感染及多重高危HPV感染,并加强治疗后随访。
  • EGI阳性者CIN2+持续/复发风险较高,可考虑更密切的随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of study was to evaluate the association of endocervical gland involvement (EGI) on histological samples with high risk (HR) human papillomavirus (HPV) infection and with the persistence/recurrence rate of cervical intraepithelial neoplasia (CIN) after treatment. METHODS: A total of 1301 subjects who had conization procedures after cervical punch biopsies (533 persistent CIN1, 768 CIN2+ including 20 microinvasive cervical cancer) were enrolled in the study. HPV genotypes were identified using the INNO-LiPA HPV genotyping assay on cervical scraping. Logistic regression and Cox regression analyses were used to evaluate the association of EGI on the persistence/recurrence rate of CIN after treatment. RESULTS: The rate of EGI on final histology was 46.3% (602/1301). HPV 16 was the only HR-HPV significantly associated with increasing rates of EGI (231/602 as compared to 211/699, p = 0.002). EGI was also associated with an excess of multiple HR-HPV infections (237/602 as compared with 225/699, p = 0.006). After correction for confounders, the odds ratio of EGI among women infected by HPV 16 was 1.41 (95% CI = 1.12-178). CIN2+ lesions were diagnosed in 40.5% (283/699) of EGI negative subjects and 86.7% (522/602, p < 0.001 compared to negative subjects) of EGI positive subjects.After a median of 25 months of follow-up (IQR = 15-47) of 1090 treated women, the persistence of HPV 16 during follow-up was 38.1% (93/217, p = 0.03 compared to EGI negative) among EGI positive and 32% (58/181) among controls. After corrections for potential confounders, the odds ratio of CIN2+ persistence and or recurrence was higher among EGI positive (OR = 2.35, 95% CI = 1.16-4.77) than negative controls. CONCLUSION: EGI on histological samples is associated with increased rates of HPV 16, multiple high risk-HPV infections and CIN2+ lesions. EGI positive subjects also had an increased CIN recurrence/persistence after treatment compared to controls.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Spinillo A, Dominoni M, Boschi AC, et al. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia. Gynecol Oncol. 2020. PMID: 33041069. doi:10.1016/j.ygyno.2020.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。